Top compounds associated with response to MT1F


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.081 0.02
mRNA niclosamide CTRPv2 pan-cancer AAC -0.085 0.02
mRNA NSC23766 CTRPv2 pan-cancer AAC 0.082 0.02
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.077 0.02
mRNA barasertib CTRPv2 pan-cancer AAC 0.074 0.02
mRNA nintedanib CTRPv2 pan-cancer AAC 0.086 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.082 0.02
mRNA BRD-K02492147 CTRPv2 pan-cancer AAC 0.093 0.02
Download CSV